TANYA GERSHMAN: Open Payments
NPI 1982321055 · WATERTOWN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,248 in 157 payments from 16 companies in 2025. Trend: 2023 $2,484 · 2024 $2,590 · 2025 $3,248
Food & beverage: $3,072Education: $176
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $525 |
| Otsuka America Pharmaceutical, Inc. | 15 | $446 |
| ABBVIE INC. | 16 | $350 |
| Alkermes, Inc. | 16 | $327 |
| Vanda Pharmaceuticals Inc. | 29 | $286 |
| Neurocrine BioSciences, Inc. | 9 | $248 |
| Braeburn Inc. | 18 | $238 |
| Indivior Inc. | 10 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $165 |
| Teva Pharmaceuticals USA, Inc. | 2 | $146 |
Products named: CAPLYTA, REXULTI, VRAYLAR, FANAPT, INGREZZA, BRIXADI, ARISTADA, SUBLOCADE.
Industry payments across MA — which companies pay providers there.
